Shoulder Innovations, Inc. insider trading
Every open-market purchase and sale by Shoulder Innovations, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Shoulder Innovations, Inc.’s insiders pay?
From September 15, 2025 to September 14, 2026, 4 insiders reported 7 open-market purchases and 6 sales not made under a pre-set plan in Shoulder Innovations, Inc. Twelve months after each purchase was reported, the shares were −3.5% against the S&P 500 on average (median −3.5%), over 2 purchases with a full year of prices; 0% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 16, 2025 into $12,306 by November 2, 2026, +20.2% a year. It held shares 100% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $11,618 (+14.2% a year), and held throughout $11,618 (+14.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Gilde Healthcare Holding B.V. | 10% owner | 0 | — | — | 5 | — | August 28, 2026 |
| Ball Robert Joseph | CEO & Executive Chairman | 3 | −3.5% (1) | 0% | 1 | — | September 14, 2026 |
| Points Jeffrey S. | Chief Financial Officer | 3 | −3.5% (1) | 0% | 0 | — | March 17, 2026 |
| Buchholz Richard | Director | 1 | — | — | 0 | — | March 17, 2026 |
When several insiders traded Shoulder Innovations, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Shoulder Innovations, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged +18.1% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| September 30, 2025 | 2 buying | +17.3% | +18.1% | +33.5% |